Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Racthera
Entity

Racthera

Tracked across 1 events · 25 articles · First seen Feb 19, 2026 · Last active Mar 06, 2026

Sentiment
70
Attention
6
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 70
Tech
Japan Approves First iPS Cell Therapies
Racthera is involved in the development of Amchepry alongside Sumitomo Pharma. The conditional approval of Amchepry is a positive development for Racthera, validating its research and development efforts in regenerative medicine.
Feb 19, 2026 · 25 articles
Relationships (1)
Sumitomo Pharma partnered with ↔ Racthera Sumitomo Pharma partnered with Racthera Inc. for the development of Amchepry.
NEWSDESK
Track Racthera live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.